The Latest Breaking News from Japan

Core consumer prices in Tokyo, considered a leading indicator of Japanese price trends, rose 1.9% in April from a year earlier, marking the fastest annual pace in seven years, government data showed on Friday.

Japanese Prime Minister Fumio Kishida said on Thursday he would loosen Japan’s virus-related border controls in line with other wealthy democracies next month, as he sought to boost consumer spending to fight an economic slowdown.

The U.S. Senate on Thursday confirmed Caroline Kennedy, a former ambassador to Japan and daughter of the late President John F. Kennedy, as the U.S. ambassador to Australia, an important ally to the United States.

U.S. President Joe Biden will discuss North Korea's nuclear and missile programs with his counterparts in South Korea and Japan during a trip to those two countries later this month, White House press secretary Jen Psaki told reporters on Thursday.

Chip Ganassi Racing-Honda’s reigning IndyCar champion and former Super Formula ace Alex Palou said he’d love for IndyCar to return to Japan.

The risk of death is high at birth and during the first years of life, but it decreases through childhood until approximately the age of 10. It then begins a steady, exponential increase that continues throughout adult life. This U-shaped curve of age-specific death rates suggests that the risk of…

By John Vandermosten, CFA NASDAQ:MDXG READ THE FULL MDXG RESEARCH REPORT

Kishida also promised increased reliance upon nuclear power for future energy independence

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) has acquired development and commercialization rights in the U.S., Europe, and other territories for Sumitomo Pharma's investigational DSP-0187. DSP-0187 is a potent, highly selective oral orexin-2 receptor agonist with potential application for treating narcolepsy, idiopathic hypersomnia, and other sleep disorders.  Jazz has designated this molecule JZP441. Sumitomo Pharma initiated a Phase…

The FDA has approved AstraZeneca plc (NASDAQ:AZN) and Daiichi Sankyo's (OTC:DSKYF) Enhertu (trastuzumab deruxtecan) for adult patients with unresectable or metastatic HER2-positive breast cancer. The approval covers patients who have received a prior anti-HER2-based regimen either in the metastatic setting or in the neoadjuvant or adjuvant setting and have developed disease recurrence during or within…

Japan will patiently seek the return of the United States to the trans-Pacific trade pact and will collaborate with Britain over the issue, Prime Minister Fumio Kishida said on Thursday.